Effect of tacrolimus in renal transplant recipients with immunoglobulin-A nephropathy.
Suzuki
K
K
Department of Medicine, Kidney Center, Tokyo Women's Medical University, Tokyo, Japan.
Tanabe
K
K
Tokumoto
T
T
Shimizu
T
T
Ishikawa
N
N
Yagisawa
T
T
Honda
K
K
Nihei
H
H
Toma
H
H
D000328:Adult; D001379:Azathioprine / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005260:Female; D005500:Follow-Up Studies; D005922:Glomerulonephritis, IGA / Q000150:complications / Q000601:surgery*; D006084:Graft Rejection / Q000453:epidemiology; D006085:Graft Survival / Q000502:physiology*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D007676:Kidney Failure, Chronic / Q000209:etiology / Q000601:surgery; D016030:Kidney Transplantation / Q000276:immunology / Q000401:mortality / Q000502:physiology*; D008297:Male; D008775:Methylprednisolone / Q000627:therapeutic use; D008875:Middle Aged; D012008:Recurrence; D012189:Retrospective Studies; D012263:Ribonucleosides / Q000627:therapeutic use; D015996:Survival Rate; D016559:Tacrolimus / Q000627:therapeutic use*; D013997:Time Factors
D007166:Immunosuppressive Agents; D012263:Ribonucleosides; C010052:mizoribine; D001379:Azathioprine; D016559:Tacrolimus; D008775:Methylprednisolone